CGTLive’s Weekly Rewind – December 16, 2022

Article

Review top news and interview highlights from the week ending December 16, 2022.

Welcome to CGTLive’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. Beti-Cel Confers Durable Efficacy, Improved Quality of Life in Beta-Thalassemia

100% of patients who achieved transfusion independence reported an overall benefit from treatment.

2. David Sallman, MD, on Advantages of Allogeneic CAR T-Cell Therapy in AML

The assistant member of the department of malignant hematology at Moffitt Cancer Center discussed unmet needs in acute myeloid leukemia and how UCART123v1.2 may address these.

3. GPRC5D-Targeted CAR T-Cell Therapy Shows Promising Efficacy After BCMA Therapy in R/R MM

New data from a phase 1/2 trial of BMS-986393 were presented at the 64th Annual ASH Meeting.

4. Akshay Sharma, MBBS, on Inducing Fetal Hemoglobin in Sickle Cell With CRISPR/Cas9-Edited Stem Cells

The assistant member of the bone marrow transplant department at St. Jude Children’s Research Hospital discussed new data from a phase 1/2 trial presented at ASH 2022.

5. SPK-8011 Yields Durable FVIII Expression in Hemophilia A

Annualized bleed rate and FVIII infusion rates significantly decreased after infusion with the gene therapy.

Recent Videos
Chun-Yu Chen, PhD, a research scientist at Seattle Children’s Research Institute
Michael Severino on In Vivo Gene Editing With RNA Gene Writers
Chris Wright, MD, PhD, on Annelloviruses, a Potential Alternative to AAV for Gene Therapy
Carol Miao, PhD, a principal investigator at Seattle Children’s Research Institute
Jacques Galipeau, MD, on Exponential Progress With Cell and Gene Therapy
Carol Miao, PhD, a principal investigator at Seattle Children’s Research Institute
Manali Kamdar, MD, on Liso-Cel's Ongoing Benefit in the Treatment Lanscape for LBCL
Manali Kamdar, MD, on The Importance of Bringing Liso-Cel to Earlier Lines of Lymphoma Treatment
Lisa Nieland on Slowing Tumor Growth in Glioblastoma With Novel AAV Therapy
Manali Kamdar, MD, on Acclimating to Routine CAR T Practice in the Field
Related Content
© 2024 MJH Life Sciences

All rights reserved.